U.S. DISEASES

U.S. COVID-19 News

U.S. COVID-19 coverage follows ongoing variants, federal vaccine and booster recommendations, long COVID research and the health policy changes that have followed the acute phase of the pandemic. Reporting takes in preparedness and the legacy questions the pandemic produced.

COVID Vaccine Patent Fight Could Shift Costs

COVID Vaccine Patent Fight Could Shift Costs

The ruling could affect future prices and availability of federally contracted vaccines like Spikevax.

Live Poll

Should drug companies be shielded from patent lawsuits over government-ordered vaccines?


Recent news


More in COVID-19

Coverage takes in variant tracking and what surveillance data shows, federal booster and vaccine guidance, long COVID research and what it finds about mechanisms and management, and the policy shifts that have followed the pandemic's acute phase. New York, Los Angeles, Chicago, Houston and Phoenix anchor reporting on where variant activity, clinical research and policy responses draw national attention. Long COVID has become a sustained subject in its own right, given the scale of people affected and the volume of research still in progress. Pandemic preparedness — what infrastructure, funding and planning exists for future outbreaks — runs alongside current outbreak coverage as a distinct strand.